跳至主要内容
临床试验/JPRN-UMIN000038168
JPRN-UMIN000038168已完成未知

A verification test of inhibition effect for acute upper respiratory tract inflammation by consumption of test food - A verification test of inhibition effect for acute upper respiratory tract inflammation by consumption of test food

CPCC Company Limited0 个研究点目标入组 72 人开始时间: 2020年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Subjects who have infected influenza between 8 months ago from informed consent and 24 hours before test start. (2) Subjects who have injected influenza vaccine within 8 months from informed consent. (3) Subjects who ingesting Food for Specified Health Use (FOSHU), functional indication food and health food on a daily bases. And subjects who will not quit ingesting them during test period. (4) Subjects who have allergy to tea, such as green tea, oolong tea, black tea and/or barley tea. (5) Subjects who have custom of drinking tea more than 2L a day. (6) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). (7) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. (8) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. (9) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. (10) Males who donated over 400mL blood and/or blood components within the last three month to the current study. (11) Females who donated over 400mL blood and/or blood components within the last four month to the current study. (12) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (13) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. (14) Others who have been determined ineligible by principal investigator or sub-investigator.

研究者

发起方
CPCC Company Limited

相似试验